Form D · Biotechnology
Tropoflex Inc.
San Antonio, TX · CIK 0002086856
Offering snapshot reported Sep 22, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2025 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558271
Source: Form D, filed Sep 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Castella | Director, Executive |
| Bryan Daniels | Director |
| Kevin Meehan | Director |
| Kristen Parker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4725 College Park Suite 200
San Antonio, TX, 78249
San Antonio, TX, 78249